Search Results 691-700 of 13532 for 📏加🍌line:sammibaby🍌了解力曼直銷🐫很瘦平胸怎麼豐胸🍛產後營養瘦身🎗新竹市腹肌贴有用吗🏷新兴区win7瘦身🛩️暴走多久才有減肥效果🐫kitty强力瘦身操2😘力量直銷
Jacksonville, Fla. This is a multi-center, open-label, Phase Ib dose escalation / Phase II study in recurrent or metastatic head and neck squamous cell ...
Title: A Multicenter Open-Label Extension Study to Assess Long-Term Safety of PF-00547659 in Subjects with Ulcerative Colitis (TURANDOT II) (TURANDOT II)
Study CRB-401 is a 2-part, non-randomized, open label, multi-site Phase 1 study of bb2121 in adults with relapsed/refractory multiple myeloma (MM). A Study ...
This is a biomarker preselected, randomized, open-label, multicenter, phase II study in men with metastatic castration resistant prostate cancer (mCRPC).
... Line Systemic Therapies for HNSCC (SEQ-HN) (AIM-HN/SEQ-HN) A Study to Evaluate the Safety and Effectiveness of Tipifarnib in Head and Neck Cancer With HRAS ...
This is a multicenter, open-label, first-in-human Phase 1 study evaluating the anti programmed death receptor 1 (anti-PD-1) antibody TSR-042 in patients ...
Title: A Phase Ib/II Open-Label, Multi-Center Study of the Safety and Efficacy of IMCgp100 in Combination with Durvalumab (MEDI4736) or Tremelimumab or the ...
Title: A Phase 3, Multicenter, Randomized, Controlled, Open-Label, Assessor-Blinded Study to Evaluate the Efficacy and Safety of Inhaled Isoflurane ...
This is a phase 3 randomized, open label study designed to evaluate the efficacy of blinatumomab versus investigator choice of SOC chemotherapy. Adult ...
... Line Platinum-Based Chemotherapy A Study of Niraparib Maintenance Treatment in Patients With Advanced Ovarian Cancer Following Response on Front-Line ...
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Make your tax-deductible gift and be a part of the cutting-edge research and care that's changing medicine.